Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01975597 · ClinicalTrials.gov registry record

Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer

A clinical trial, sponsored by University of Michigan Rogel Cancer Center.

Terminated
Registry status
8
Enrollment target

NCT01975597 is a clinical trial that was terminated before completion, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 8 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01975597 was terminated before completion, sponsored by University of Michigan Rogel Cancer Center.

TERMINATED
Registry status
8 participants
Enrollment target

Study Summary

This is a feasibility study to demonstrate the team's ability to collect bone marrow aspirates and biopsies for research purposes from women with metastatic breast cancer.

Interventions

  • PROCEDURE Bone marrow aspirates and biopsy

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2013-08
Est. Completion 2014-11-19

What the Registry Record Tells You About NCT01975597

The ClinicalTrials.gov registry entry for NCT01975597 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Bone marrow aspirates and biopsy is the first listed.

NCT01975597 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01975597 about?

NCT01975597 is a clinical study titled "Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer". This is a feasibility study to demonstrate the team's ability to collect bone marrow aspirates and biopsies for research purposes from women with metastatic breast cancer.

What is the current status of trial NCT01975597?

This trial is currently terminated. The enrollment target is 8 participants. The study started on 2013-08. Estimated completion is 2014-11-19.

What interventions are being tested in trial NCT01975597?

The interventions under investigation include: Bone marrow aspirates and biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT01975597?

This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.